FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,182 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 12,201

 

Start Prev Rows 6000 - 6200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1089.jsonUnilateral Mastectomy, Unspecified Lateralityactive2017-12hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1090.jsonUnilateral Mastectomy, Unspecified Lateralityactive2017-12hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1091.jsonStatus Post Left Mastectomyactive2017-12hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1092.jsonStatus Post Right Mastectomyactive2017-12hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1096.jsonMajor Transplantactive2021-09hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1097.jsonMajor Transplantactive2021-08hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1132.jsonUnilateral Mastectomy Leftactive2021-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1133.jsonUnilateral Mastectomy Rightactive2021-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1134.jsonHysterectomy with No Residual Cervixactive2023-09hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1135.jsonHysterectomy with No Residual Cervixactive2020-03hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1140.jsonBilateral Mastectomyactive2019-03hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1143.jsonTotal Colectomyactive2019-03hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1144.jsonUnilateral Mastectomy Leftactive2019-03hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1145.jsonUnilateral Mastectomy Rightactive2019-03hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1148.jsonPalliative Interventionactive2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1005.jsonBilateral Mastectomyactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1006.jsonPrimary THA Procedureactive2023-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1010.jsonFlexible Sigmoidoscopyactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1011.jsonFecal Occult Blood Test (FOBT)active2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1012.jsonGroup A Streptococcus Testactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1013.jsonHbA1c Laboratory Testactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1014.jsonHysterectomy with No Residual Cervixactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1019.jsonTotal Colectomyactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1034.jsonXRay Studyactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1050.jsonGastric Bypass Surgeryactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1068.jsonHistory of bilateral mastectomyactive2017-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1069.jsonStatus Post Left Mastectomyactive2017-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1070.jsonStatus Post Right Mastectomyactive2017-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1071.jsonUnilateral Mastectomy, Unspecified Lateralityactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1075.jsonMajor Transplantactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1133.jsonUnilateral Mastectomy Leftactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1134.jsonUnilateral Mastectomy Rightactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1135.jsonPalliative Care Interventionactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1064.jsonAnaphylactic Reaction to DTaP Vaccineactive2022-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1100.jsonMalabsorption Syndromesactive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1102.jsonMalabsorption Syndromesactive2022-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1105.jsonIntussusceptionactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1106.jsonIntussusceptionactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1107.jsonInfluenza Virus LAIV Vaccineactive2021-02hl7cvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1108.jsonInfluenza Virus LAIV Vaccine Administeredactive2021-02hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.12.1031.jsonAnaphylactic Reaction to DTaP Vaccineactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.12.1050.jsonMalabsorption Syndromesactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.12.1056.jsonIntussusceptionactive2017-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2446.jsonLower Extremity Visual Inspection Testactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2447.jsonPedal Pulse Result or Findingactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2448.jsonMonofilament Test Result or Findingactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2449.jsonMonofilament Testsactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2450.jsonLower Extremity Neurological Assessment Result or Findingactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2451.jsonLower Extremity Neurological Testsactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2452.jsonLower Extremity Visual Inspection Result or Findingactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2616.jsonAutonomous Eye Exam Result or Findingactive2025-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.1577.jsonPharmacologic Therapy for Hypertensionactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1036.jsonChronic Kidney Disease, Stage 5active2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1037.jsonChronic Kidney Disease, Stage 5active2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1049.jsonPatient Provider Interactionactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1058.jsonPsych Visit for Family Psychotherapyactive2017-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1063.jsonOccupational Therapy Evaluationactive2017-08hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1067.jsonDementia and Mental Degenerationsactive2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1068.jsonDementia and Mental Degenerationsactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1069.jsonStandardized Tools for Assessment of Cognitionactive2017-05hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1071.jsonRadiation Treatment Managementactive2017-08hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1072.jsonRadiation Treatment Managementactive2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1073.jsonStandardized Pain Assessment Toolactive2017-05hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1078.jsonCanceractive2025-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1079.jsonCanceractive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1080.jsonChemotherapy Administrationactive2024-01hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1081.jsonChemotherapy Administrationactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.111.jsonOphthalmological Servicesactive2021-02hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.113.jsonProstate Cancer Treatmentactive2025-02hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.118.jsonInitial Myocardial Infarctionactive2020-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.119.jsonInitial Myocardial Infarctionactive2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.120.jsonCoronary Artery Disease No MIactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1238.jsonEjection Fractionactive2025-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1243.jsonPsychoanalysisactive2017-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1244.jsonRenal Failure Due to ACE Inhibitoractive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1251.jsonGroup Psychotherapyactive2017-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1256.jsonAllergy to ACE Inhibitor or ARBactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1257.jsonIntolerance to ACE Inhibitor or ARBactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.133.jsonBeta Blocker Therapyactive2023-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1333.jsonAllergy to Beta Blocker Therapyactive2019-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1334.jsonIntolerance to Beta Blocker Therapyactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1341.jsonHeart Rateactive2024-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1342.jsonBeta Blocker Therapy for LVSDactive2022-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1344.jsonAcute and Subacute Iridocyclitisactive2025-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1353.jsonLimited Life Expectancyactive2025-04hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1363.jsonAnnual Wellness Visitactive2023-12hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1364.jsonMacular Examactive2021-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1372.jsonTobacco Use Screeningactive2017-05hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1374.jsonBone Scanactive2018-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1377.jsonLevel of Severity of Retinopathy Findingsactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1381.jsonMacular Edema Findings Presentactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1401.jsonCognitive Assessmentactive2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1402.jsonCup to Disc Ratioactive2021-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1403.jsonOptic Disc Exam for Structural Abnormalitiesactive2021-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1509.jsonAcute and Subacute Iridocyclitisactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1521.jsonBurn Confined to Eye and Adnexaactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1523.jsonBurn Confined to Eye and Adnexaactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1524.jsonCataract Secondary to Ocular Disordersactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1526.jsonCataract Secondary to Ocular Disordersactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1527.jsonCataract Surgeryactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1528.jsonCataract Surgeryactive2025-01hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1529.jsonCataract Congenitalactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1530.jsonCataract Congenitalactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1532.jsonCataract Mature or Hypermatureactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1534.jsonCataract Mature or Hypermatureactive2025-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1535.jsonCataract Posterior Polaractive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1537.jsonCataract Posterior Polaractive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1538.jsonCertain Types of Iridocyclitisactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1540.jsonCertain Types of Iridocyclitisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1542.jsonChronic Iridocyclitisactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1543.jsonChronic Iridocyclitisactive2025-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1544.jsonCloudy Corneaactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1546.jsonCloudy Corneaactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1548.jsonCorneal Edemaactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1549.jsonCorneal Edemaactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1550.jsonDisorders of Cornea Including Corneal Opacityactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1552.jsonDisorders of Cornea Including Corneal Opacityactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1561.jsonGlaucomaactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1562.jsonGlaucomaactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1564.jsonHereditary Corneal Dystrophiesactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1566.jsonHereditary Corneal Dystrophiesactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1571.jsonHypotony of Eyeactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1572.jsonHypotony of Eyeactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1574.jsonInjury to Optic Nerve and Pathwaysactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1575.jsonInjury to Optic Nerve and Pathwaysactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1577.jsonCentral Corneal Ulceractive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1578.jsonCentral Corneal Ulceractive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1582.jsonOpen Wound of Eyeballactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1583.jsonOpen Wound of Eyeballactive2025-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1587.jsonPathologic Myopiaactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1588.jsonPathologic Myopiaactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1590.jsonPosterior Lenticonusactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1591.jsonPosterior Lenticonusactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1601.jsonRetrolental Fibroplasiasactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1603.jsonRetrolental Fibroplasiasactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1612.jsonTraumatic Cataractactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1613.jsonTraumatic Cataractactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1615.jsonUveitisactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1617.jsonUveitisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1618.jsonVascular Disorders of Iris and Ciliary Bodyactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1620.jsonVascular Disorders of Iris and Ciliary Bodyactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1621.jsonVisual Field Defectsactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1623.jsonVisual Field Defectsactive2022-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1626.jsonAmblyopiaactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1628.jsonAmblyopiaactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1632.jsonChoroidal Degenerationsactive2025-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1634.jsonChoroidal Degenerationsactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1635.jsonChoroidal Detachmentactive2024-12hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1637.jsonChoroidal Detachmentactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1638.jsonChoroidal Hemorrhage and Ruptureactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1640.jsonChoroidal Hemorrhage and Ruptureactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1641.jsonDegeneration of Macula and Posterior Poleactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1643.jsonDegeneration of Macula and Posterior Poleactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1644.jsonDegenerative Disorders of Globeactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1646.jsonDegenerative Disorders of Globeactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1647.jsonDiabetic Macular Edemaactive2025-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1649.jsonDiabetic Macular Edemaactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1653.jsonDisorders of Optic Chiasmactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1655.jsonDisorders of Optic Chiasmactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1656.jsonDisorders of Visual Cortexactive2021-04hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1658.jsonDisorders of Visual Cortexactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1659.jsonDisseminated Chorioretinitis and Disseminated Retinochoroiditisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1661.jsonDisseminated Chorioretinitis and Disseminated Retinochoroiditisactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1662.jsonFocal Chorioretinitis and Focal Retinochoroiditisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1664.jsonFocal Chorioretinitis and Focal Retinochoroiditisactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1665.jsonGlaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromesactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1667.jsonGlaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromesactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1668.jsonHereditary Choroidal Dystrophiesactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1670.jsonHereditary Choroidal Dystrophiesactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1671.jsonHereditary Retinal Dystrophiesactive2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1673.jsonHereditary Retinal Dystrophiesactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1677.jsonNystagmus and Other Irregular Eye Movementsactive2021-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1679.jsonNystagmus and Other Irregular Eye Movementsactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1680.jsonOptic Atrophyactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1682.jsonOptic Atrophyactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1683.jsonOptic Neuritisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1685.jsonOptic Neuritisactive2022-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1686.jsonOther and Unspecified Forms of Chorioretinitis and Retinochoroiditisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1688.jsonOther and Unspecified Forms of Chorioretinitis and Retinochoroiditisactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1689.jsonOther Background Retinopathy and Retinal Vascular Changesactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1691.jsonOther Background Retinopathy and Retinal Vascular Changesactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1695.jsonOther Disorders of Optic Nerveactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1697.jsonOther Disorders of Optic Nerveactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1701.jsonOther Endophthalmitisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1703.jsonOther Endophthalmitisactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1707.jsonPrior Penetrating Keratoplastyactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1709.jsonPrior Penetrating Keratoplastyactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1713.jsonPurulent Endophthalmitisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1715.jsonPurulent Endophthalmitisactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1716.jsonRetinal Detachment with Retinal Defectactive2022-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1718.jsonRetinal Detachment with Retinal Defectactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1719.jsonRetinal Vascular Occlusionactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1721.jsonRetinal Vascular Occlusionactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1722.jsonOther Proliferative Retinopathyactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1724.jsonOther Proliferative Retinopathyactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1728.jsonSeparation of Retinal Layersactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1730.jsonSeparation of Retinal Layersactive2025-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1731.jsonVisual Acuity 20/40 or Betteractive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.175.jsonHypotensionactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1752.jsonSpeech and Hearing Evaluationactive2017-05hl7cpt